Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

XTL executives say rebels are 'opportunistic'

Stephen Foley
Tuesday 20 May 2003 19:00 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Renegade shareholders plotting to oust the executive team at XTL Biopharmaceuticals are "opportunistic financiers" planning to take control of the company's cash and assets to make a quick profit, the Israeli biotech group said yesterday.

The company has been forced to put the rebel shareholders' requests to a rescheduled annual meeting next month, but set out a robust response in a letter to shareholders.

Shore Capital, a combative City investment boutique, has amassed a 17 per cent stake and says it wants the company - which is trying to develop a treatment for hepatitis C - to slash executive pay and other costs to avoid running out of money.

XTL argues Shore would find it difficult to shut down or sell the drug development business as it plans, since these would require the agreement of scientists and developers and may trigger the repayment of grants to the Israeli government.

XTL shares have jumped from 6p when Shore began stakebuilding earlier this month, but were down 0.25p at 9.75p yesterday.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in